Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
Hypogonadism increases likelihood of hospitalization for men with COVID-19
Men with hypogonadism who contract COVID-19 are more likely to be hospitalized compared with those with normal testosterone levels, according to study findings published in JAMA Network Open.
CDC recommends bivalent COVID-19 boosters
The CDC’s vaccine advisory committee on Thursday voted to recommend the bivalent COVID-19 booster vaccines authorized this week by the FDA that also target the omicron variant of SARS-CoV-2.
Log in or Sign up for Free to view tailored content for your specialty!
Only half of eligible people in US are boosted against COVID-19
As of Aug. 5, approximately half of all eligible Americans aged 5 years or older had received their first COVID-19 booster vaccine, according to data published Thursday in MMWR.
Study shows more than 158,000 administrations of deauthorized COVID-19 treatments
Despite being deauthorized by the FDA on Jan. 24, 2022, due to omicron variant inefficiency, two monoclonal antibody treatments were administered more than 158,000 times to patients with COVID-19, according to a study in JAMA Network Open.
US life expectancy further declines, largely due to COVID-19
Life expectancy in the United States has declined for the second consecutive year, reaching levels that have not been seen since 1996, according to provisional data from the CDC.
FDA authorizes updated COVID-19 booster vaccines
The FDA on Wednesday authorized bivalent COVID-19 booster vaccines from Moderna and Pfizer-BioNTech for emergency use in the United States.
Study finds regular physical activity linked to lower risk for COVID-19, mortality
Regular physical activity was associated with a lower risk for developing COVID-19 and experiencing adverse outcomes of COVID-19, including severe disease and mortality, a study published in the British Journal of Sports Medicine found.
Moderna sues Pfizer, BioNTech over patents related to COVID-19 vaccine
Moderna said Friday that it is filing lawsuits against Pfizer and BioNTech alleging that their COVID-19 messenger RNA vaccine infringes on patents crucial to the development of Moderna's mRNA vaccine.
Pfizer says RSV vaccine candidate safe, effective in older adults
Pfizer reported Thursday that its vaccine candidate for respiratory syncytial virus was nearly 86% effective in preventing severe illness in a phase 3 clinical trial of older adults.
Shorter antibiotic durations are better for some pediatric infections
Most patients when filling an antibiotic prescription are counseled to “take all of the antibiotic to complete the course, even if you feel better.”